Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rami Komrokji

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Blood|January 14, 2025
How I treat higher-risk MDSAlain Mina, Rami Komrokji
Expert Review of Hematology|December 11, 2012
Assessing efficacy in myelofibrosis treatment: a focus on JAK inhibitionRami Komrokji, Srdan Verstovsek
Journal of the National Comprehensive Cancer Network : JNCCN|September 4, 2020
What's in a Number? Examining the Prognostic and Predictive Importance of Platelet Count in Patients With Essential ThrombocythemiaAndrew T Kuykendall, Rami Komrokji
Current Hematology Reports|August 7, 2003
The myelodysplastic syndromes: classification and prognosisRami Komrokji, John M Bennett
Expert Review of Hematology|February 17, 2011
Biology and treatment of the 5q- syndromeEric Padron, Rami Komrokji, Alan F List
Best Practice & Research. Clinical Haematology|December 6, 2021
It is time to shift the treatment paradigm in myelodysplastic syndromes: A focus on novel developments and current investigational approaches exploring combinatorial therapy in high-risk MDSLuis E Aguirre, Rami Komrokji, Eric Padron
Current Treatment Options in Oncology|October 4, 2011
The 5q- syndrome: biology and treatmentEric Padron, Rami Komrokji, Alan F List
Clinical Advances in Hematology & Oncology : H&O|June 14, 2014
The clinical management of chronic myelomonocytic leukemiaEric Padron, Rami Komrokji, Alan F List
Expert Opinion on Emerging Drugs|August 4, 2016
Emerging biological therapies for the treatment of myelodysplastic syndromesAmer M Zeidan, Maximilian Stahl, Rami Komrokji
Blood and Lymphatic Cancer : Targets and Therapy|October 1, 2025
The Ongoing Challenges of Managing Cytopenic Myelofibrosis in 2025: The Emergence of Non-JAK Inhibitor TherapiesSamuel B Reynolds, Rami Komrokji, Andrew T Kuykendall
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Blood|January 14, 2025
How I treat higher-risk MDSAlain Mina, Rami Komrokji
Expert Review of Hematology|December 11, 2012
Assessing efficacy in myelofibrosis treatment: a focus on JAK inhibitionRami Komrokji, Srdan Verstovsek
Journal of the National Comprehensive Cancer Network : JNCCN|September 4, 2020
What's in a Number? Examining the Prognostic and Predictive Importance of Platelet Count in Patients With Essential ThrombocythemiaAndrew T Kuykendall, Rami Komrokji
Current Hematology Reports|August 7, 2003
The myelodysplastic syndromes: classification and prognosisRami Komrokji, John M Bennett
Expert Review of Hematology|February 17, 2011
Biology and treatment of the 5q- syndromeEric Padron, Rami Komrokji, Alan F List
Best Practice & Research. Clinical Haematology|December 6, 2021
It is time to shift the treatment paradigm in myelodysplastic syndromes: A focus on novel developments and current investigational approaches exploring combinatorial therapy in high-risk MDSLuis E Aguirre, Rami Komrokji, Eric Padron
Current Treatment Options in Oncology|October 4, 2011
The 5q- syndrome: biology and treatmentEric Padron, Rami Komrokji, Alan F List
Clinical Advances in Hematology & Oncology : H&O|June 14, 2014
The clinical management of chronic myelomonocytic leukemiaEric Padron, Rami Komrokji, Alan F List
Expert Opinion on Emerging Drugs|August 4, 2016
Emerging biological therapies for the treatment of myelodysplastic syndromesAmer M Zeidan, Maximilian Stahl, Rami Komrokji
Blood and Lymphatic Cancer : Targets and Therapy|October 1, 2025
The Ongoing Challenges of Managing Cytopenic Myelofibrosis in 2025: The Emergence of Non-JAK Inhibitor TherapiesSamuel B Reynolds, Rami Komrokji, Andrew T Kuykendall
Pageof 13